High expression of SOX30 is associated with favorable survival in human lung adenocarcinoma

In our previous study, we had identified SOX30 as a novel tumor suppressor that acts through direct regulation of p53 transcription in human lung cancer. Here, we sought to determine the clinical relevance of SOX30 expression in a series of surgically-resected non-small cell lung cancer (NSCLC) pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Fei, Liu, Wenbin, Xiao, Hualiang, Dong, Yan, Sun, Lei, Mao, Chengyi, Yin, Li, Jiang, Xiao, Ao, Lin, Cui, Zhihong, Cao, Jia, Liu, Jinyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557060/
https://www.ncbi.nlm.nih.gov/pubmed/26330328
http://dx.doi.org/10.1038/srep13630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557060/
https://www.ncbi.nlm.nih.gov/pubmed/26330328
http://dx.doi.org/10.1038/srep13630

Ejemplares similares